Paper457181
Rimantadine but not amantadine protects Fischer rat embryo cells from transformation induced by 3-methylcholanthrene or benzo(a)pyrene.
Price PJ and 2 others. In Vitro, 1979. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Rimantadine but not amantadine protects Fischer rat embryo cells from transformation induced by 3-methylcholanthrene or benzo(a)pyrene. Papers, record 457181. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/457181
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Rimantadine but not amantadine protects Fischer rat embryo cells from transformation induced by 3-methylcholanthrene or benzo(a)pyrene.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adamantane | Major topic |
| Amantadine | Major topic |
| Benzopyrenes | Major topic |
| Bridged-Ring Compounds | Major topic |
| Cell Transformation, Neoplastic | Major topic |
| Methylcholanthrene | Major topic |
| Animals | |
| Cell Line | |
| Rats |
Source PubMed
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 280,146 | Selective inhibition of RNA tumor virus replication in vitro and evaluation of candidate antiviral agents in vivo. | Ann N Y Acad Sci | 1977 | https://conductscience.org/library/papers/280146 | PubMed |
| 2 | 70,789 | Geldanamycin inhibition of 3-methylcholanthrene-induced rat embryo cell transformation. | Proc Soc Exp Biol Med | 1977 | https://conductscience.org/library/papers/70789 | PubMed |
| 3 | 50,281 | I. In vitrol transformation of rat embryo cells: correlations with the known tumorigenic activities of chemicals in rodents. | In Vitro | 1975 | https://conductscience.org/library/papers/50281 | PubMed |
| 4 | 4,857,140 | Streptonigrin inhibition of 3-methylcholanthrene transformation in vitro. | Proc Soc Exp Biol Med | 1974 | https://conductscience.org/library/papers/4857140 | PubMed |
| 5 | 280,137 | The relative potencies of anti-influenza compounds. | Ann N Y Acad Sci | 1977 | https://conductscience.org/library/papers/280137 | PubMed |
| 6 | 5,781,863 | Inhibition of uncoating of fowl plague virus by l-adamantanamine hydrochloride. | Virology | 1969 | https://conductscience.org/library/papers/5781863 | PubMed |
| 7 | 54,927 | Cordycepin inhibition of 3-methylcholanthrene-induced transformation in vitro. | Proc Soc Exp Biol Med | 1975 | https://conductscience.org/library/papers/54927 | PubMed |
| 8 | 4,289,900 | Effect of 1-adamantanamine hydrochloride on Rous sarcoma virus in vitro and in vivo. | Eur J Cancer (1965) | 1966 | https://conductscience.org/library/papers/4289900 | PubMed |
| 9 | 4,307,232 | Alpha-methyl-1-adamantane-methylamine hydrochloride: inhibition of Rous and Esh sarcoma viruses in cell culture. | Proc Soc Exp Biol Med | 1969 | https://conductscience.org/library/papers/4307232 | PubMed |
| 10 | 714,954 | 9-beta-D-Arabinofuranosyladenine inhibition of chemically induced rat embryo cell transformation. | Proc Soc Exp Biol Med | 1978 | https://conductscience.org/library/papers/714954 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/457181
GET https://conductscience.org/api/papers/v1/457181/authors